A complete response with daratumumab, venetoclax, azacitidine and dexamethasone in a heavily pre-treated, chemo-refractory early T-precursor acute lymphoblastic leukemia/lymphoma patient

Related articles

1. Adult Patients with Philadelphia-Positive B-Cell Acute Lymphoblastic Leukemia Treated with a Pediatric-Inspired Multiagent Chemotherapy Regimen, in Combination with a TKI, Do Not Require Routine alloSCT

   This article has 16 authors:

   1. Donna Zhe Sian Eng
   2. Fatime Khadadah
   3. Maria Agustina Perusini
   4. Eshrak Al Shaibani
   5. Eshetu G. Atenafu
   6. Aniket Bankar
   7. Marta Davidson
   8. Guillaume Richard-Carpentier
   9. Dawn Maze
   10. Karen Yee
   11. Aaron Schimmer
   12. Vikas Gupta
   13. Steven Chan
   14. Dennis Dong Hwan Kim
   15. Andre Schuh
   16. Hassan Sibai

2. Long-term follow-up results of anti-BCMA CAR-T cell therapy combined with autologous hematopoietic stem cell transplantation in relapsed/refractory multiple myeloma with extramedullary disease

   This article has 10 authors:

   1. Xin Li
   2. Can Liu
   3. Siyan Niu
   4. Ru Li
   5. Shuquan Gao
   6. Rui Cui
   7. Jia Wang
   8. Yao Qi
   9. Jingyi Li
   10. Qi Deng

3. Low-dose CD7 chimeric antigen receptor T cells for relapsed/refractory T-cell lymphomas: single-arm, open-label, phase I study

   This article has 13 authors:

   1. Kai Hu
   2. Fan Yang
   3. Rui Liu
   4. Zhonghua Fu
   5. Yuelu Guo
   6. Lixia Ma
   7. Miaomiao Cao
   8. Biping Deng
   9. Alex H. Chang
   10. Haifeng Wu
   11. Shilin Gan
   12. Chen Chen
   13. Xiaoyan Ke